share

Febuxostat Impurity 14 CAS NO 1335202-60-2


Unit Price:

CAS No.:1335202-60-2

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Febuxostat Impurity 14 is a designated pharmaceutical reference standard used for analytical and quality control purposes. This compound is critical for ensuring the purity, safety, and efficacy of the active pharmaceutical ingredient (API) Febuxostat during its development and manufacturing. It is primarily required by pharmaceutical companies, contract research organizations (CROs), and analytical laboratories involved in method development, stability studies, and regulatory compliance testing for gout medication.

Application

  • Pharmaceutical Reference Standard: Used as a certified impurity standard for the identification and quantification of related substances in Febuxostat API and finished dosage forms.
  • Analytical Method Development & Validation: Essential for developing and validating sensitive HPLC, UPLC, or LC-MS methods to monitor impurity profiles.
  • Quality Control & Batch Release Testing: Employed in routine QC labs to ensure Febuxostat batches meet stringent pharmacopeial (e.g., USP, EP) and ICH guidelines for impurity limits.
  • Stability Studies: Used to track the formation of this specific degradation product under various stress conditions (e.g., heat, light, humidity) to establish product shelf-life.
  • Regulatory Submissions: Provides necessary data for Drug Master Files (DMFs), Investigational New Drug (IND), and New Drug Application (NDA) submissions to agencies like the FDA and EMA.
  • Research & Development: Supports process chemistry research to understand and minimize the formation of this impurity during API synthesis.

Basic Information

Product Name Febuxostat Impurity 14
CAS No. 1335202-60-2
Molecular Formula C16H16N2O3S
Molecular Weight 316.38 g/mol
Synonyms Febuxostat Related Compound 14; 2-[(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid; Febuxostat EP Impurity I; Febuxostat USP Impurity; Febuxostat Process Impurity; Thiazolecarboxylic acid derivative impurity of Febuxostat
EINECS Contact for details

Quality Control

Our Febuxostat Impurity 14 is manufactured under strict quality systems. Each batch undergoes comprehensive analytical characterization using techniques such as HPLC, GC, NMR, and MS to confirm identity and purity, ensuring it meets the stringent requirements for use as a pharmaceutical reference standard. A comprehensive Certificate of Analysis (COA) detailing batch-specific results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent absorption of moisture.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Purity (HPLC) ≥ 95.0%
Related Substances (HPLC) Total impurities ≤ 5.0% Any individual unspecified impurity ≤ 1.0%
Residual Solvents (GC) Complies with ICH Q3C guidelines
Water Content (KF) ≤ 5.0% w/w

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.